Cecilia A. Cotton

Cecilia A. Cotton

Auto-generated profile, based on publicly available information

Cecilia A. Cotton

Department of Statistics and Actuarial Science University of Waterloo Waterloo Ontario Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2019 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
JFJill Furzer
Jill Furzer
LTLauren Tessier
Lauren Tessier
DHDavid Hodgson
David Hodgson
CCCecilia Cotton
Cecilia Cotton
Paul NathanPaul Nathan
Paul Nathan
PPPetros Pechlivanoglou
Petros Pechlivanoglou
Background: Adolescent women treated for Hodgkin lymphoma (HL) are at increased risk of breast cancer (BC). We evaluate the cost-utility of eight high-risk BC surveillance strategies for this population, including the Children’s Oncology Group guideline of same-day annual mammography and magnetic resonance imaging (MRI) beginning at age 25 years. Methods: A discrete event simulation model was used to simulate the life histories of a cohort of 500 000 25-year-old women treated for HL at age 15 years. We estimated BC incidence and mortality, life expectancy, quality-adjusted life-years (QALYs), health-care costs, and the relative cost-utility (incremental cost-utility ratio [ICUR]) under the eight assessed surveillance strategies. One-way sensitivity analysis enabled modeling of uncertainty evaluation. A publicly funded health-care payer perspective was adopted. Results: Costs across the eight screening strategies ranged from $32 643 to $43 739, whereas QALYs ranged from 24.419 to 24.480. In an incremental cost-effectiveness analysis, annual mammography beginning at age 25 years was associated with an ICUR of $43 000/QALY gained, annual MRI beginning at age 25 years with a switch to annual mammography at age 50 years had an ICUR of $148 000/QALY, and annual MRI beginning at age 25 years had an ICUR of $227 222/QALY. Among all assessed surveillance strategies, the differences in life expectancy were small. Conclusions: Current high-risk BC surveillance guidelines do not reflect the most cost-effective strategy in survivors of adolescent HL. The results suggest that groups at high risk of BC may require high-risk surveillance guidelines that reflect their specific risk profile.

16 May 2022 in Biostatistics & Epidemiology
Verified
Journal Article
Closed access
MCM. S. Cuerden
M. S. Cuerden
LDLiqun Diao
Liqun Diao
CCC. A. Cotton
C. A. Cotton
RCRichard John Cook
Richard John Cook
Health research often aims to investigate whether the effect of an exposure variable is common across different subgroups of individuals, but sometimes the variable defining subgroups is not recorded in all individuals. We propose and evaluate two methods for estimation of the marginal causal effect of an exposure variable within subgroups in the observational setting where the subgroup variable is incompletely observed. The first approach involves doubly weighted estimating functions with one weight based on a propensity score for exposure and a second weight addressing the selection bias when analyses are restricted to individuals with complete data. The second approach uses the inverse probability of exposure weights in conjunction with multiple imputation for the incomplete subgroup variable. The resulting estimators are consistent when the auxiliary models are correctly specified; we assess the finite sample performance via simulation. An illustrative analysis is provided involving patients with psoriatic arthritis treated with biologic therapy where interest lies in the effect of therapy according to the presence or absence of the human leukocyte antigen marker HLA-B27 which is incompletely observed.

15 May 2018 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
YZYayuan Zhu
Yayuan Zhu
JLJerald F. Lawless
Jerald F. Lawless
CCCecilia A. Cotton
Cecilia A. Cotton

9 June 2023 in Statistics in Medicine
Verified
Journal Article
Open access
WZWenling Zhang
Wenling Zhang
CCCecilia A. Cotton
Cecilia A. Cotton
Researchers often work with treatments and outcomes that vary over time. For example, psychologists are interested in the curative effect of cognitive behavior therapies on patients' recurrent depression symptoms. While there are various causal effect measures designed for one-time treatment, the causal effect measures for time-varying treatment and recurrent events are relatively under-developed. In this article, a new causal measure is proposed to quantify the causal effect of time-varying treatments on recurrent events. We suggest estimators with robust standard errors that are based on various weight models for both conventional causal measures and the proposed measure in different time settings. We outline the approaches and describe how using some stabilized inverse probability weight models are more advantageous than others. We demonstrate that the proposed causal estimand can be consistently estimated for study periods of moderate length, and the estimation results are compared under different treatment settings with various weight models. We also find that the proposed method is suitable for both absorbing and nonabsorbing treatments. The methods are applied to the 1997 National Longitudinal Study of Youth as an illustrative example.

19 January 2023 in Communications in Statistics - Theory and Methods
Verified
Journal Article
Closed access
MCMeaghan S. Cuerden
Meaghan S. Cuerden
LDLiqun Diao
Liqun Diao
CCCecilia A. Cotton
Cecilia A. Cotton
RCRichard John Cook
Richard John Cook
Effect modification plays a central role in stratified medicine, of which the goal is often to find biomarker profiles that identify individuals who benefit from a treatment of interest. We consider the problem of causal inference regarding the effect modifying role of a biomarker, which is only available for some individuals in an observational study. We develop inverse probability weighted mean score estimating functions with one weight to account for confounding and a second weight for the missing data process. An iterative approach is described for solving the equations in the spirit of the expectation-maximization algorithm, and large sample properties of the resulting estimator are developed. Simulation studies are conducted to compare the proposed method with a doubly weighted complete case analysis and a propensity score weighted multiple imputation approach. An application to a study of the effect of a biologic therapy on inflammation in a rheumatology cohort is given for illustration.